Kiadis shares yo-yo on cell therapy trial for COVID-19Shares in Netherlands biotech Kiadis rose sharply on the news that it would start developing a natural killer Share XKiadis shares yo-yo on cell therapy trial for COVID-19https://pharmaphorum.com/news/kiadis-shares-yo-yo-on-cell-therapy-trial-for-covid-19/
Kiadis sheds half its staff as lead cell therapy bombsDutch biotech Kiadis Pharma has abandoned its lead cell therapy and axed half its workforce after a failed Share XKiadis sheds half its staff as lead cell therapy bombshttps://pharmaphorum.com/news/kiadis-sheds-half-its-staff-as-lead-cell-therapy-bombs/
